Agilent SAMHSA-Compliant LC/MS/MS Analysis of 11-nor-9-carboxy-D9-Tetrahydrocannabinol in Urine with Agilent Bond Elut Plexa PCX Agilent Poroshell 120 Manual
Update: 29 September, 2023
This document presents a method for SAMHSA-compliant LC/MS/MS analysis using Agilent Bond Elut Plexa PCX and Agilent Poroshell 120. The method meets SAMHSA guidelines and provides measurement of linearity, limit of detection (LOD), accuracy and precision, matrix effects, extraction recovery, and overall process efficiency. The method utilizes premier Agilent products including Agilent Bond Elut Plexa PCX mixed-mode polymeric SPE sorbent, Agilent Poroshell 120 EC-C18 2.7 µm superficially porous LC column, Agilent 1200 Infinity LC system, and Agilent 6460 Triple Quadrupole LC/MS system.
File format: PDF
Size: -
MD5 Checksum: 7B959C84FE0F13B7987FDB58751FC9B6
Publication date: 11 June, 2012
Downloads: -
PDF Link:
Agilent SAMHSA-Compliant LC/MS/MS Analysis of 11-nor-9-carboxy-D9-Tetrahydrocannabinol in Urine with Agilent Bond Elut Plexa PCX Agilent Poroshell 120 Manual PDF